Volume 25, Issue 8, August 2023

Review

Editor's Choice

Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review

Jasmin Jo and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1381–1394, https://doi.org/10.1093/neuonc/noad059

• Abstract
• View article
• Supplementary data

Metadata Analysis/Systematic Review

Cognitive outcomes after multimodal treatment in adult glioma patients: A meta-analysis

Laurien De Roeck and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1395–1414, https://doi.org/10.1093/neuonc/noad045

• Abstract
• View article
• Supplementary data

Basic and Translational Investigation

Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease

Chao-Hsien Chen and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1415–1427, https://doi.org/10.1093/neuonc/noad025

• Abstract
• View article
• Supplementary data

Basic and Translational Investigation

Novel INHAT repressor drives glioblastoma growth by promoting ribosomal DNA transcription in glioma stem cells

Weiwei Tao and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1428–1440, https://doi.org/10.1093/neuonc/noac272

• Abstract
• View article
• Supplementary data

Editorial

Sabotaging the protein factory to overcome glioma stem cell resistance

Santiago Haase and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1441–1442, https://doi.org/10.1093/neuonc/noad090

• Extract
• View article

Basic and Translational Investigation

Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033

Johan M Kros and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1443–1449, https://doi.org/10.1093/neuonc/noac282

• Abstract
• View article
• Supplementary data

Editorial

Mitotic index is (still) important for grading isocitrate dehydrogenase (IDH)-mutant astrocytoma

Kaleigh F Roberts and Sonika M Dahiya

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1450–1451, https://doi.org/10.1093/neuonc/noad063

• Extract
• View article

Basic and Translational Investigation

Editor's Choice

Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification

Jeffrey A Zuccato and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1452–1460, https://doi.org/10.1093/neuonc/noac264

• Abstract
• View article
• Supplementary data

Editorial

Cerebrospinal fluid: The new frontier for methylome-based diagnostic classification of brain tumors

Alexandra M Miller and Matthias A Karajannis

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1461–1462, https://doi.org/10.1093/neuonc/noad075

• Extract
• View article

Basic and Translational Investigation

Molecular changes underlying decay of sensory responses and enhanced seizure propensity in peritumoral neurons

Elena Tantillo and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1463–1473, https://doi.org/10.1093/neuonc/noad035

• Abstract
• View article
• Supplementary data

Clinical Investigations

Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1

Carlos G Romo and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1474–1486, https://doi.org/10.1093/neuonc/noad033

• Abstract
• View article

Primary papillary epithelial tumor of the sella and posterior pituitary tumor show similar (epi)genetic features and constitute a single neuro-oncological entity

Jing Feng and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1487–1497, https://doi.org/10.1093/neuonc/noad067

• Abstract
• View article
• Supplementary data

Pediatric Neuro-Oncology

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma

Scott R Plotkin and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1498–1506, https://doi.org/10.1093/neuonc/noad066

• Abstract
• View article

Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening

Marija Kojic and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1507–1517, https://doi.org/10.1093/neuonc/noad032

• Abstract
• View article
• Supplementary data

Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups

Svenja Tonn and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1518–1529, https://doi.org/10.1093/neuonc/noad027

• Abstract
• View article
• Supplementary data

Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908

Ira J Dunkel and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1530–1545, https://doi.org/10.1093/neuonc/noad031

• Abstract
• View article
• Supplementary data

Letters to the Editor

Letter concerning “Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival”: Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma

Vincenzo Di Nunno and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1546–1547, https://doi.org/10.1093/neuonc/noad071

• Extract
• View article

Reply to Di Nunno et al. concerning objective response rates targets for recurrent glioblastoma clinical trials: Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma

Benjamin M Ellingson and others

Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1548–1549, https://doi.org/10.1093/neuonc/noad085

• Extract
• View article

Society News

Forthcoming Meetings

Neuro-Oncology, Volume 25, Issue 8, August 2023, Page 1550, https://doi.org/10.1093/neuonc/noad123

• Extract
• View article